EUVIMEDEUVIMED entdecken
Crossref

Determination of Clinically Acceptable Analytical Variation of Cardiac Troponin at Decision Thresholds

John W Pickering iD, Peter Kavsak iD, Robert H Christenson iD, Richard W Troughton iD, Christopher J Pemberton iD, A Mark Richards iD, Laura Joyce iD, Martin P Than iD

Clinical Chemistry · 05.07.2024 · 70 (7) · 967-977

DOI: 10.1093/clinchem/hvae059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Chemistry, online erschienen am 07.05.2024. Verfasst von John W Pickering und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Emergency Care Foundation, Christchurch Hospital, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Myocardial Infarction, Troponin T, Troponin I. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical decision-making for risk stratification for possible myocardial infarction (MI) uses high-sensitivity cardiac troponin (hs-cTn) thresholds that range from the limit of detection to several-fold higher than the upper reference limit (URL). To establish a minimum analytical variation standard, we can quantify the effect of variation on the population clinical measures of safety (sensitivity) and effectiveness [proportion below threshold, or positive predictive value (PPV)].

Methods

From large datasets of patients investigated for possible MI with the Abbott hs-cTnI and Roche hs-cTnT assays, we synthesized datasets of 1 000 000 simulated patients. Troponin concentrations were randomly varied several times based on absolute deviations of 0.5 to 3 ng/L and relative changes of 2% to 20% around the low-risk threshold (5 ng/L) and URLs, respectively.

Results

For both assays at the low-risk thresholds, there were negligible differences in sensitivity (<0.3%) with increasing analytical variation. The proportion of patients characterized as low risk reduced by 30% to 29% (Roche) and 53% to 44% (Abbott). At the URL, increasing analytical variation also did not change sensitivity; the PPV fell by less than 3%. For risk stratification, increased delta thresholds (change between serial troponin concentrations) increased sensitivity at the cost of a decreased percentage of patients below the delta threshold, with the largest changes at the greatest analytical variation.

Conclusions

At the low-risk threshold, analytical variation up to 3 ng/L minimally impacted the safety metric (sensitivity) but marginally reduced effectiveness. Similarly, at the URL even relative variation up to 25% minimally impacted safety metrics and effectiveness. Analytical variation for delta thresholds did not negatively impact sensitivity but decreased effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionTroponin TTroponin IHumans

Substanzen

Troponin TTroponin I

Autor:innen und Institutionen

  • Department of Emergency Medicine, Emergency Care Foundation, Christchurch Hospital, Christchurch, New Zealand.
  • Department of Medicine, Christchurch Heart Institute, University of Otago Christchurch, Christchurch, New Zealand.
  • Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
  • Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, United States.
  • Department of Emergency Medicine, Christchurch Hospital, Christchurch, New Zealand.
  • Department of Surgery and Critical Care, University of Otago Christchurch, Christchurch, New Zealand.

ORCID-Profile: John W Pickering, Peter Kavsak, Robert H Christenson, Richard W Troughton, Christopher J Pemberton, A Mark Richards, Laura Joyce, Martin P Than

Zitieren

APA

Pickering, J. W., Kavsak, P., Christenson, R. H., Troughton, R. W., Pemberton, C. J., Richards, A. M., Joyce, L., & Than, M. P. (2024). Determination of Clinically Acceptable Analytical Variation of Cardiac Troponin at Decision Thresholds. Clinical Chemistry, 70(7), 967-977. https://doi.org/10.1093/clinchem/hvae059

Vancouver

Pickering JW, Kavsak P, Christenson RH, Troughton RW, Pemberton CJ, Richards AM, et al. Determination of Clinically Acceptable Analytical Variation of Cardiac Troponin at Decision Thresholds. Clinical Chemistry. 2024;70(7):967-977. doi:10.1093/clinchem/hvae059

BibTeX
@article{Pickering2024,
  author = {Pickering, John W and Kavsak, Peter and Christenson, Robert H and Troughton, Richard W and Pemberton, Christopher J and Richards, A Mark and Joyce, Laura and Than, Martin P},
  title = {Determination of Clinically Acceptable Analytical Variation of Cardiac Troponin at Decision Thresholds},
  journal = {Clinical Chemistry},
  year = {2024},
  volume = {70},
  number = {7},
  pages = {967--977},
  doi = {10.1093/clinchem/hvae059}
}
Kostenlos starten →